Amendment 037 - DRIVe EZ BAA.pdf
PDF 135 KB Posted
- Attached to
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
- Solicitation number
- DRIVeEZBAA22100SOL00003
About this file
This document is Amendment #037 to the Easy Broad Agency Announcement (EZBAA) issued by the Office of Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation & Ventures (DRIVe) on April 22, 2025. The amendment announces the immediate closure of three specific Areas of Interest (AOIs): AOI #19: Healing Lungs, AOI #20: ReBooT, and AOI #29: Type to Treat.
The amendment states that no new initial submissions will be accepted for these AOIs, and no additional initial awards will be executed. However, eligible "+Phase" submissions will still be accepted and reviewed according to the EZBAA and corresponding AOI processes. Respondents with pending initial submissions prior to this amendment will be directly notified that no initial awards will be made. For future updates, interested parties are advised to monitor www.drive.hhs.gov or contact the specific AOI resource inboxes provided in the document.
View the file
Other files
Show all 39
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
EZBAA-22-100-SOL-00003 Amendment #037
Office of Biomedical Advanced Research and Development Authority
Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement EZBAA-22-100-SOL-00003
April 22, 2025
The purpose of Amendment #037 is the following:
As we work to optimize program and acquisition strategies, the closing dates for the following Areas of Interest (AOI) have been revised to close effective immediately:
AOI #19: Healing Lungs (HealingLungs@hhs.gov)
AOI #20: ReBooT (ReBoot@hhs.gov)
AOI #29: Type to Treat (TyPE@hhs.gov)
For the above listed AOI’s, initial submissions will no longer be accepted and no additional initial awards will be executed.
Respondents with pending initial submissions received prior to the date of this amendment, if any, will be notified directly that no initial awards will be executed. Note: eligible +Phase submissions will still be accepted and reviewed in accordance the process outlined the EZBAA and corresponding AOI.
For programmatic updates to these important areas of work please continue to monitor www.drive.hhs.gov or reach out to the resource inbox corresponding to the AOI, as noted above. We greatly appreciate your interest and look forward to future engagement.
mailto:HealingLungs@hhs.gov mailto:reboot@hhs.gov mailto:TyPE@hhs.gov http://www.drive.hhs.gov/
| Office of Biomedical Advanced Research and Development Authority |
| Division of Research, Innovation & Ventures (DRIVe) |
| Easy Broad Agency Announcement EZBAA-22-100-SOL-00003 |
| April 22, 2025 |
| The purpose of Amendment #037 is the following: |
| As we work to optimize program and acquisition strategies, the closing dates for the following Areas of Interest (AOI) have been revised to close effective immediately: |
| AOI #19: Healing Lungs (HealingLungs@hhs.gov) |
| AOI #20: ReBooT (ReBoot@hhs.gov) |
| AOI #29: Type to Treat (TyPE@hhs.gov) |
| For the above listed AOI’s, initial submissions will no longer be accepted and no additional initial awards will be executed. Respondents with pending initial submissions received prior to the date of this amendment, if any, will be notified directly ... |
| For programmatic updates to these important areas of work please continue to monitor www.drive.hhs.gov or reach out to the resource inbox corresponding to the AOI, as noted above. We greatly appreciate your interest and look forward to future engageme... |
File details come from the government source that posted it. Updated .